interleukin-1beta (163-171) has been researched along with cysteamine in 2 studies
| Studies (interleukin-1beta (163-171)) | Trials (interleukin-1beta (163-171)) | Recent Studies (post-2010) (interleukin-1beta (163-171)) | Studies (cysteamine) | Trials (cysteamine) | Recent Studies (post-2010) (cysteamine) |
|---|---|---|---|---|---|
| 192 | 3 | 74 | 3,307 | 60 | 666 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keenan, CM; Mugridge, KG; Parente, L; Wallace, JL | 1 |
| Cornelissen, EAM; Elmonem, MA; Hohenfellner, K; Janssen, MC; Levtchenko, E; Prencipe, G; van den Heuvel, LP; Van Dyck, M; Veys, KRP | 1 |
2 other study(ies) available for interleukin-1beta (163-171) and cysteamine
| Article | Year |
|---|---|
Reduction of the severity of experimental gastric and duodenal ulceration by interleukin-1 beta.
Topics: Animals; Cysteamine; Duodenal Ulcer; Ethanol; Indomethacin; Injections, Intraperitoneal; Interleukin-1; Interleukin-1beta; Male; Peptide Fragments; Rats; Rats, Inbred Strains; Recombinant Proteins; Stomach Ulcer | 1990 |
Chitotriosidase as a Novel Biomarker for Therapeutic Monitoring of Nephropathic Cystinosis.
Topics: Adolescent; Adult; Biomarkers; Child; Cysteamine; Cystine; Cystinosis; Drug Monitoring; Female; Hexosaminidases; Humans; Inflammation; Interleukin-18; Interleukin-1beta; Interleukin-6; Leukocytes; Macrophage Activation; Male; Medication Adherence; Peptide Fragments; Prospective Studies; Young Adult | 2020 |